Company Profile For Merck KGaA

Merck KGaA (MRCG.DE) (Xetra)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  25 Nov 2009
66.42EUR
Price Change
+0.42
Percent Change
+0.64%
 
 
Research a stock:   symbol lookup

Overview

Merck KGaA is a Germany-based company, operating in the pharmaceutical and chemical business sectors. The Pharmaceuticals business includes the development and production of prescription drugs and over-the-counter products, and operates through the Merck Serono division, which focuses on the research activities in such areas as oncology, neurodegenerative diseases and fertility, among others, and the Consumer Health Care division that offers a range of products for everyday health. The Chemicals business sector offers a range of specialty chemicals for various technology applications, and operates through the Liquid Crystals division, which is engaged in the development and production of liquid crystals (LC), and the Performance and Life Science Chemicals division that specializes in the expertise in application technology, quality assurance and approval processes. In 2008, the Company acquired Bio-Fyt, a Belgian company. Merck KGaA is represented in 61 countries worldwide.

Quick Financial Synopsis

BRIEF: For the nine months ended 30 September 2009, Merck KGaA's total revenue increased 1% to EUR5.7B. Net income from continuing operations decreased 52% to EUR309.5M. Total revenue reflects an increase in demand for the Company's products and services in the Merck Serono and Consumer Health Care business segments. Net income from continuing operations was offset by higher marketing and selling expenses and other operating expenses.

Company Address

Merck KGaA
Frankfurter Strasse 250
Darmstadt     64293
P: +496151.720
F: +496151.722000

Total Employees

32832

Find Out More About MRCG.DE

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement